• Mashup Score: 1

    WASHINGTON — Patients with COPD on budesonide/glycopyrrolate/formoterol fumarate within 30 days of an exacerbation had fewer future exacerbations, according to data presented at the American Thoracic Society International Conference.“Exacerbations and Real-world Outcomes [EROS] informs us that triple therapy begun immediately after both moderate and severe exacerbations improved

    Tweet Tweets with this article
    • “... triple therapy begun immediately after both moderate and severe #exacerbations improved outcomes compared to all combinations of #inhalers that were used in the month before the index exacerbation,” Charlie Strange, MD, at @MedUnivSC, told Healio. https://t.co/lh9wbqE9zy

  • Mashup Score: 0

    FRIDAY, Nov. 11, 2022 (HealthDay News) — It’s a potentially deadly issue: Some U.S. school administrators don’t keep life-saving albuterol asthma inhalers on hand because they’re afraid of getting sued for misuse. That’s true even in states like Illinois, where strong “stock albuterol” laws are on …

    Tweet Tweets with this article
    • Liability Fears Keep Some Schools From Stocking Asthma Inhalers @AllergyAsthmaHQ Read more in the article below: https://t.co/h9lzfu9HNa #asthma #inhalers #school #Health #healthnews #healthday #healthcare #medical #hospital #nurse #surgery #doctor #healthandwellness